|
|
 |
Vaccine
Information Statements
VISs by language
Laotian-language VISs
Up-to-date
You
are encouraged to distribute the up-to-date English-language
VIS at the same time
as the translation.
Oral polio vaccine is no longer
available for use in the United States. These VISs are available
on our website for the convenience of people outside the United
States who choose to use them.
|
|
|
Laotian-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are
encouraged to distribute the up-to-date
English-language VIS
at the same time as the translation.
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added
information on MMRV.
- The URL for
Vaccine Adverse Event Reporting System (VAERS) has changed to
www.vaers.hhs.gov.
- The URL for the
National Vaccine Injury Compensation Programs has changed to
www.hrsa.gov/vaccincompensation.
These translations do not contain the following
CDC updates:
- These translations do not contain the following CDC updates
- The main change is in Section 4, which now mentions Tdap.
- The NVICP and VAERS web addresses have also been updated
- The mortality rate for tetanus in Section 1 changed from 1 out of
10, to 2 out of 10 cases.
- The date changed to 5/17/07.
This translation does not contain the
following CDC updates:
- CDC changed the
indication to 1 year or older and has recommended routine use for
children.
- Section 2: Added
persons who work with primates or in research labs to indications
(routine vaccination).
- Added bullet for
"persons who live in communities that have prolonged outbreaks of
hepatitis A."
- Divided the
section into "Who" and "When" parts.
- Removed southern
Europe from list of regions with high rates of hepatitis A.
- Section 3: Added
bullet about allergy to vaccine component.
- Changed wording,
particularly the statement on pregnancy, and made list into
bullets.
- Minor changes to
part 4, 5, and 6 to be consistent with other recent VISs.
- Removed the
section on immune globulin.
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an interim
VIS for hepatitis B. There are minor changes throughout, but the main
purpose of the update is to emphasize the birth dose for all children.
- A final version will be developed.
This translation does not contain the
following CDC updates:
- CDC added
recommending vaccination of children aged 24-59 months and their
contacts.
- Section
1: Influenza is now described as "very contagious." Fatigue is
listed as a complication of the disease.
- Section
2: Information about 2004 Institute of Medicine report about
thimerosal was added. It also says "If you are concerned about
thimerosal, ask your doctor about thimerosal-free influenza
vaccine."
- Section
3: CDC added to the list of people at high risk for complications
from influenza, "People with certain muscle or nerve disorders
(such as seizure disorders or severe cerebral palsy) that can lead
to breathing or swallowing disorders."
- Section 5: The
first paragraph has some changes. the last sentence (about
simultaneous administration) is simpler.
- Section 7: The
VAERS website changed to www.vaers.hhs.gov
- Section 8: CDC
added live influenza vaccine to the National Vaccine Injury
Compensation Program.
This translation does not contain the
following CDC updates:
- Female patients
are now advised to postpone pregnancy for 4 weeks after receiving
MMR vaccine (version 12/16/98 read "3 months")
- The website of the
Vaccine Adverse Event Reporting System has been added.
- A new URL for the
National Vaccine Injury Compensation Program has been added.
This translation does not contain the
following CDC updates:
- Information on the
projected 3-year duration of protection has been deleted (it's
likely much longer)
- An upper age limit
"under 5 years" has been placed on vaccinating children over the
age of two years who are at increased risk of serious pneumococcal
disease.
- The website of the
Vaccine Adverse Event Reporting System, www.vaers.org has been
added.
- A new URL for the
National Vaccine Injury Compensation Program has been added.
You will be linked to the CDC
website, to download the Smallpox pre-vaccination information
packet, which includes the Smallpox VIS.
Please note: there are supplements that come
with this VIS, but the supplements have not been translated,
just the VIS.
Thanks to
the Minnesota Department of Health and the California Department
of Health Services for their translations.This page was updated on
March 13, 2008 |
|
|
IAC Home